# NKA Bio, Inc. — Form D

NKA Bio, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-03. The offering totals $2.0M, of which $30K was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2023-04-03
- Form: D
- Accession: 0001967539-23-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $30K
- Remaining: $2.0M
- Investors: 3
- Date of first sale: 2023-03-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-477761

## Issuer

- Name: NKA Bio, Inc.
- CIK: 0001967539
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 2401 WEST BELVEDERE AVENUE, BALTIMORE, MD, 21215
- Phone: 443-465-7702

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Lewis C Hibbs | Director | Baltimore, MD |
| Susan G Hibbs | Director | Baltimore, MD |
| Les E Johnson | Director | Baltimore, MD |
| Lewis C Hibbs | Executive Officer | Baltimore, MD |
| Susan G Hibbs | Executive Officer | Baltimore, MD |
| Les E Johnson | Executive Officer | Baltimore, MD |

## More

- [CIK 1967539 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1967539&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001967539-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.